STATE STREET CORP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$13,815,973
-19.1%
2,535,041
-0.4%
0.00%0.0%
Q2 2023$17,074,454
-24.7%
2,544,628
-0.9%
0.00%0.0%
Q1 2023$22,671,747
-40.7%
2,568,042
-48.7%
0.00%0.0%
Q4 2022$38,222,202
+116.8%
5,002,906
+102.0%
0.00%0.0%
Q3 2022$17,632,000
-6.8%
2,476,435
+5.9%
0.00%0.0%
Q2 2022$18,926,000
-27.3%
2,339,384
+24.8%
0.00%0.0%
Q1 2022$26,018,000
-43.1%
1,874,471
+14.9%
0.00%
-50.0%
Q4 2021$45,763,000
-11.8%
1,630,890
+6.9%
0.00%
-33.3%
Q3 2021$51,861,000
-11.1%
1,525,758
+6.9%
0.00%0.0%
Q2 2021$58,304,000
+51.9%
1,426,921
+49.6%
0.00%
+50.0%
Q1 2021$38,390,000
-32.0%
953,543
-0.2%
0.00%
-33.3%
Q4 2020$56,489,000
+26.2%
955,334
+3.8%
0.00%0.0%
Q3 2020$44,767,000
+13.8%
920,567
+13.2%
0.00%0.0%
Q2 2020$39,350,000
+98.4%
813,357
+13.9%
0.00%
+50.0%
Q1 2020$19,832,000
+155.1%
713,896
+174.7%
0.00%
+100.0%
Q4 2019$7,775,000
+70.4%
259,853
+76.0%
0.00%
Q3 2019$4,562,000147,6310.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders